Loading clinical trials...
Loading clinical trials...
Individual Patient Expanded Access IND to Evaluate the Safety and Preliminary Efficacy of Autologous HB-adMSCs for the Treatment of Stroke
Conditions
Interventions
HB-adMSCs
Locations
1
United States
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, United States
Last Updated
September 29, 2025
NCT05093673
NCT06258538
NCT07371455
NCT06870812
NCT07253181
NCT04119544
Lead Sponsor
Hope Biosciences Research Foundation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions